PROSTAGUTT F caps 120 pce

7680526240291 CH-52624 G04CX02 05.98.0.
PROSTAGUTT F caps 120 pce
PROSTAGUTT F caps 120 pce
PROSTAGUTT F caps 120 pce
1 / 3
google

Details

Product number
5262401
CPT
-
Packaging group
120
Unit
Kapsel(n)
Composition
Sabalis serrulatae extractum (Serenoa repens (W.Bartram) Small, fructus) 160 mg, DER: 10-14.3:1, Auszugsmittel Ethanolum 93 % (V/V), urticae radicis extractum ethanolicum siccum (Urtica urens L., Urtica dioica L., radix) 120 mg, DER: 7.6-12.5:1, Auszugsmittel Ethanolum 68% (V/V), silica colloidalis anhydrica, sojae oleum hydrogenatum 10-63.6 mg, adeps solidus, Kapselhülle: succinogelatina, glycerolum (85 per centum), E 131, E 172 (flavum), E 172 (nigrum), pro capsula.

Articles (1)

Prostagutt F, Kapseln
Kapseln
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/08/2022
Patient information leaflet
Français
24/08/2022
Patient information leaflet
Italien
24/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Authorization holder

Schwabe Pharma AG

6403 Küssnacht am Rigi

Authorization information

Swissmedic authorization number
52624
Drug name
Prostagutt F, Kapseln
Galenic form
KAPS
ATC Code
G04CX02
Authorization status
Z
Dispensation category
D
First authorization
27/04/1995
Authorization expiration date
31/12/9999
IT number
05.98.0.
Domain
Human medicine
Field of application
Bei beginnender Prostatavergrösserung

Packaging details

Description (FR)
PROSTAGUTT F caps 120 pce
Description (DE)
PROSTAGUTT F Caps 120 Stk
Market launch
27/04/1995
Narcotic (BTM)
No

Other packaging sizes